Le Lézard
Classified in: Health, Science and technology, Business
Subjects: EARNINGS, Conference Call, Webcast, Advisory

UroGen Pharma to Report Fourth Quarter and Full-Year 2022 Financial Results on Thursday, March 16, 2023


UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it will report fourth quarter and full-year 2022 financial results on Thursday, March 16, 2023, prior to the open of the stock market. The announcement will be followed by a live audio webcast and conference call at 10:00 AM Eastern Time.

A live public webcast of the earnings conference call can be accessed on UroGen's Investor Relations website. Following the live webcast, a replay will be available on the site for approximately 30 days.

About UroGen Pharma Ltd.

UroGen is a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers because patients deserve better options. UroGen has developed RTGeltm reverse-thermal hydrogel, a proprietary sustained release, hydrogel-based platform technology that has the potential to improve therapeutic profiles of existing drugs. UroGen's sustained release technology is designed to enable longer exposure of the urinary tract tissue to medications, making local therapy a potentially more effective treatment option. UroGen's first commercial product Jelmyto® (mitomycin) for pyelocaliceal solution and investigational treatment UGN-102 (mitomycin) for intravesical solution are designed to ablate tumors by non-surgical means. UroGen is headquartered in Princeton, NJ with operations in Israel. Visit www.urogen.com to learn more or follow us on Twitter, @UroGenPharma.


These press releases may also interest you

at 18:00
LANESBOROUGH REIT PROVIDES UPDATE ON FUTURE PLANS AND ANNOUNCES RESIGNATION OF INDEPENDENT TRUSTEES
Lanesborough Real Estate Investment Trust ("LREIT") today provided an update with regards to its plans for future operations following the failure by the holders of its trust units ("Unitholders") to approve a special resolution approving the sale...

at 18:00
Kindred welcomes Jason Daly as our new CEO
Following an extensive search, Kindred Credit Union (Kindred) is pleased to announce Jason Daly as our next chief executive officer. Jason will assume the role on September 1, 2024. As a seasoned financial services executive, Jason has led teams in...

at 17:44
PenFed Foundation and The 9:57 Project Partner to Celebrate Independence Day and Honor Nation's Veterans at Washington Nationals Game
The PenFed Foundation, a national 501(c)3 founded by PenFed Credit Union, and The 9:57 Project, a veteran-educator nonprofit partnership, celebrated Independence Day and our nation's veterans during pre-game festivities before the July 4 Washington...

at 17:18
Canadian Investment Regulatory Organization Trading Halt - LRT.UN
The following issues have been halted by CIRO Company: Lanesborough Real Estate Investment Trust TSX-Venture Symbol: LRT.UN All Issues: Yes Reason: Pending News Halt Time (ET): 4:59 PM CIRO can make a decision to impose a temporary suspension...

at 17:05
Media Advisory: TransAlta Second Quarter 2024 Results and Conference Call
TransAlta will release its second quarter 2024 results before markets open on Thursday, August 1, 2024. A conference call and webcast to discuss the results will be held for investors, analysts, members of the media and other interested parties the...

at 17:05
Ratification of new collective agreement for Kruger Products' Crabtree plant and Joliette warehouse
KP Tissue Inc. which has a limited equity interest in Kruger Products Inc. (the "Company"), is pleased to announce that the 482 unionized employees at its Crabtree plant and Joliette warehouse have ratified a new five-year collective agreement. "We...

More news about Business...


News published on and distributed by: